0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-aging and Longevity Drugs Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-21E18520
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti aging and Longevity Drugs Market Research Report 2024
BUY CHAPTERS

Global Anti-aging and Longevity Drugs Market Research Report 2024

Code: QYRE-Auto-21E18520
Report
November 2024
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-aging and Longevity Drugs Market

The global Anti-aging and Longevity Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Anti-aging products are designed to help users improve their appearance and prevent aging, while longevity products focus more on product durability and market vitality. As people's living standards improve, the demand for anti-aging and longevity products will continue to increase.
North American market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-aging and Longevity Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-aging and Longevity Drugs include The Vitamin Shoppe, Natrol, HUM Nutrition, Nature Made, New Chapter, Centrum, Pure Encapsulations, Nature's Bounty, MegaFood, GNC, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-aging and Longevity Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging and Longevity Drugs.
The Anti-aging and Longevity Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Anti-aging and Longevity Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-aging and Longevity Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti-aging and Longevity Drugs Market Report

Report Metric Details
Report Name Anti-aging and Longevity Drugs Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company The Vitamin Shoppe, Natrol, HUM Nutrition, Nature Made, New Chapter, Centrum, Pure Encapsulations, Nature's Bounty, MegaFood, GNC, Herbalmax, GeneHarbor (Hong Kong) Biotechnologies Limited, Xiamen Kingdomway Group Company, Shinkowa, Yaben Chemical, Guangdong Zhongsheng Pharmaceutical Co.,Ltd., China Resources Double-Crane Pharmaceutical Co.,Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti-aging and Longevity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti-aging and Longevity Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Anti-aging and Longevity Drugs Market report?

Ans: The main players in the Anti-aging and Longevity Drugs Market are The Vitamin Shoppe, Natrol, HUM Nutrition, Nature Made, New Chapter, Centrum, Pure Encapsulations, Nature's Bounty, MegaFood, GNC, Herbalmax, GeneHarbor (Hong Kong) Biotechnologies Limited, Xiamen Kingdomway Group Company, Shinkowa, Yaben Chemical, Guangdong Zhongsheng Pharmaceutical Co.,Ltd., China Resources Double-Crane Pharmaceutical Co.,Ltd.

What are the Application segmentation covered in the Anti-aging and Longevity Drugs Market report?

Ans: The Applications covered in the Anti-aging and Longevity Drugs Market report are Hospitals, Retail Pharmacies, Clinics, Online Pharmacies

What are the Type segmentation covered in the Anti-aging and Longevity Drugs Market report?

Ans: The Types covered in the Anti-aging and Longevity Drugs Market report are Nicotinamide Mononucleotide (NMN), Vitamins, Resveratrol, Coenzyme Q10 and Collagen, Biotin, Others

Recommended Reports

Anti-Aging Drugs & Therapy

Beauty & Skincare

Cognitive & Healthy Aging

1 Anti-aging and Longevity Drugs Market Overview
1.1 Product Definition
1.2 Anti-aging and Longevity Drugs by Type
1.2.1 Global Anti-aging and Longevity Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Nicotinamide Mononucleotide (NMN)
1.2.3 Vitamins
1.2.4 Resveratrol
1.2.5 Coenzyme Q10 and Collagen
1.2.6 Biotin
1.2.7 Others
1.3 Anti-aging and Longevity Drugs by Application
1.3.1 Global Anti-aging and Longevity Drugs Market Value by Application (2024-2030)
1.3.2 Hospitals
1.3.3 Retail Pharmacies
1.3.4 Clinics
1.3.5 Online Pharmacies
1.4 Global Anti-aging and Longevity Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-aging and Longevity Drugs Revenue 2019-2030
1.4.2 Global Anti-aging and Longevity Drugs Sales 2019-2030
1.4.3 Global Anti-aging and Longevity Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-aging and Longevity Drugs Market Competition by Manufacturers
2.1 Global Anti-aging and Longevity Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-aging and Longevity Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-aging and Longevity Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Anti-aging and Longevity Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-aging and Longevity Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-aging and Longevity Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti-aging and Longevity Drugs, Date of Enter into This Industry
2.8 Global Anti-aging and Longevity Drugs Market Competitive Situation and Trends
2.8.1 Global Anti-aging and Longevity Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti-aging and Longevity Drugs Players Market Share by Revenue
2.8.3 Global Anti-aging and Longevity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-aging and Longevity Drugs Market Scenario by Region
3.1 Global Anti-aging and Longevity Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-aging and Longevity Drugs Sales by Region: 2019-2030
3.2.1 Global Anti-aging and Longevity Drugs Sales by Region: 2019-2024
3.2.2 Global Anti-aging and Longevity Drugs Sales by Region: 2025-2030
3.3 Global Anti-aging and Longevity Drugs Revenue by Region: 2019-2030
3.3.1 Global Anti-aging and Longevity Drugs Revenue by Region: 2019-2024
3.3.2 Global Anti-aging and Longevity Drugs Revenue by Region: 2025-2030
3.4 North America Anti-aging and Longevity Drugs Market Facts & Figures by Country
3.4.1 North America Anti-aging and Longevity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-aging and Longevity Drugs Sales by Country (2019-2030)
3.4.3 North America Anti-aging and Longevity Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-aging and Longevity Drugs Market Facts & Figures by Country
3.5.1 Europe Anti-aging and Longevity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-aging and Longevity Drugs Sales by Country (2019-2030)
3.5.3 Europe Anti-aging and Longevity Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-aging and Longevity Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-aging and Longevity Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-aging and Longevity Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Anti-aging and Longevity Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-aging and Longevity Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti-aging and Longevity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-aging and Longevity Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anti-aging and Longevity Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-aging and Longevity Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-aging and Longevity Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-aging and Longevity Drugs Sales by Type (2019-2030)
4.1.1 Global Anti-aging and Longevity Drugs Sales by Type (2019-2024)
4.1.2 Global Anti-aging and Longevity Drugs Sales by Type (2025-2030)
4.1.3 Global Anti-aging and Longevity Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anti-aging and Longevity Drugs Revenue by Type (2019-2030)
4.2.1 Global Anti-aging and Longevity Drugs Revenue by Type (2019-2024)
4.2.2 Global Anti-aging and Longevity Drugs Revenue by Type (2025-2030)
4.2.3 Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anti-aging and Longevity Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-aging and Longevity Drugs Sales by Application (2019-2030)
5.1.1 Global Anti-aging and Longevity Drugs Sales by Application (2019-2024)
5.1.2 Global Anti-aging and Longevity Drugs Sales by Application (2025-2030)
5.1.3 Global Anti-aging and Longevity Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anti-aging and Longevity Drugs Revenue by Application (2019-2030)
5.2.1 Global Anti-aging and Longevity Drugs Revenue by Application (2019-2024)
5.2.2 Global Anti-aging and Longevity Drugs Revenue by Application (2025-2030)
5.2.3 Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anti-aging and Longevity Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 The Vitamin Shoppe
6.1.1 The Vitamin Shoppe Company Information
6.1.2 The Vitamin Shoppe Description and Business Overview
6.1.3 The Vitamin Shoppe Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 The Vitamin Shoppe Anti-aging and Longevity Drugs Product Portfolio
6.1.5 The Vitamin Shoppe Recent Developments/Updates
6.2 Natrol
6.2.1 Natrol Company Information
6.2.2 Natrol Description and Business Overview
6.2.3 Natrol Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Natrol Anti-aging and Longevity Drugs Product Portfolio
6.2.5 Natrol Recent Developments/Updates
6.3 HUM Nutrition
6.3.1 HUM Nutrition Company Information
6.3.2 HUM Nutrition Description and Business Overview
6.3.3 HUM Nutrition Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HUM Nutrition Anti-aging and Longevity Drugs Product Portfolio
6.3.5 HUM Nutrition Recent Developments/Updates
6.4 Nature Made
6.4.1 Nature Made Company Information
6.4.2 Nature Made Description and Business Overview
6.4.3 Nature Made Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nature Made Anti-aging and Longevity Drugs Product Portfolio
6.4.5 Nature Made Recent Developments/Updates
6.5 New Chapter
6.5.1 New Chapter Company Information
6.5.2 New Chapter Description and Business Overview
6.5.3 New Chapter Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 New Chapter Anti-aging and Longevity Drugs Product Portfolio
6.5.5 New Chapter Recent Developments/Updates
6.6 Centrum
6.6.1 Centrum Company Information
6.6.2 Centrum Description and Business Overview
6.6.3 Centrum Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Centrum Anti-aging and Longevity Drugs Product Portfolio
6.6.5 Centrum Recent Developments/Updates
6.7 Pure Encapsulations
6.7.1 Pure Encapsulations Company Information
6.7.2 Pure Encapsulations Description and Business Overview
6.7.3 Pure Encapsulations Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Pure Encapsulations Anti-aging and Longevity Drugs Product Portfolio
6.7.5 Pure Encapsulations Recent Developments/Updates
6.8 Nature's Bounty
6.8.1 Nature's Bounty Company Information
6.8.2 Nature's Bounty Description and Business Overview
6.8.3 Nature's Bounty Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Nature's Bounty Anti-aging and Longevity Drugs Product Portfolio
6.8.5 Nature's Bounty Recent Developments/Updates
6.9 MegaFood
6.9.1 MegaFood Company Information
6.9.2 MegaFood Description and Business Overview
6.9.3 MegaFood Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 MegaFood Anti-aging and Longevity Drugs Product Portfolio
6.9.5 MegaFood Recent Developments/Updates
6.10 GNC
6.10.1 GNC Company Information
6.10.2 GNC Description and Business Overview
6.10.3 GNC Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GNC Anti-aging and Longevity Drugs Product Portfolio
6.10.5 GNC Recent Developments/Updates
6.11 Herbalmax
6.11.1 Herbalmax Company Information
6.11.2 Herbalmax Description and Business Overview
6.11.3 Herbalmax Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Herbalmax Anti-aging and Longevity Drugs Product Portfolio
6.11.5 Herbalmax Recent Developments/Updates
6.12 GeneHarbor (Hong Kong) Biotechnologies Limited
6.12.1 GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
6.12.2 GeneHarbor (Hong Kong) Biotechnologies Limited Description and Business Overview
6.12.3 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product Portfolio
6.12.5 GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments/Updates
6.13 Xiamen Kingdomway Group Company
6.13.1 Xiamen Kingdomway Group Company Company Information
6.13.2 Xiamen Kingdomway Group Company Description and Business Overview
6.13.3 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product Portfolio
6.13.5 Xiamen Kingdomway Group Company Recent Developments/Updates
6.14 Shinkowa
6.14.1 Shinkowa Company Information
6.14.2 Shinkowa Description and Business Overview
6.14.3 Shinkowa Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Shinkowa Anti-aging and Longevity Drugs Product Portfolio
6.14.5 Shinkowa Recent Developments/Updates
6.15 Yaben Chemical
6.15.1 Yaben Chemical Company Information
6.15.2 Yaben Chemical Description and Business Overview
6.15.3 Yaben Chemical Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Yaben Chemical Anti-aging and Longevity Drugs Product Portfolio
6.15.5 Yaben Chemical Recent Developments/Updates
6.16 Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
6.16.1 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
6.16.2 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Description and Business Overview
6.16.3 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
6.16.5 Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments/Updates
6.17 China Resources Double-Crane Pharmaceutical Co.,Ltd.
6.17.1 China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
6.17.2 China Resources Double-Crane Pharmaceutical Co.,Ltd. Description and Business Overview
6.17.3 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product Portfolio
6.17.5 China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-aging and Longevity Drugs Industry Chain Analysis
7.2 Anti-aging and Longevity Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-aging and Longevity Drugs Production Mode & Process
7.4 Anti-aging and Longevity Drugs Sales and Marketing
7.4.1 Anti-aging and Longevity Drugs Sales Channels
7.4.2 Anti-aging and Longevity Drugs Distributors
7.5 Anti-aging and Longevity Drugs Customers
8 Anti-aging and Longevity Drugs Market Dynamics
8.1 Anti-aging and Longevity Drugs Industry Trends
8.2 Anti-aging and Longevity Drugs Market Drivers
8.3 Anti-aging and Longevity Drugs Market Challenges
8.4 Anti-aging and Longevity Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-aging and Longevity Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Anti-aging and Longevity Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Anti-aging and Longevity Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Anti-aging and Longevity Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Anti-aging and Longevity Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Anti-aging and Longevity Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Anti-aging and Longevity Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Anti-aging and Longevity Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Anti-aging and Longevity Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti-aging and Longevity Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti-aging and Longevity Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anti-aging and Longevity Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-aging and Longevity Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-aging and Longevity Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-aging and Longevity Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Anti-aging and Longevity Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Anti-aging and Longevity Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Anti-aging and Longevity Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Anti-aging and Longevity Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Anti-aging and Longevity Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Anti-aging and Longevity Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Anti-aging and Longevity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Anti-aging and Longevity Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Anti-aging and Longevity Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Anti-aging and Longevity Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Anti-aging and Longevity Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Anti-aging and Longevity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Anti-aging and Longevity Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Anti-aging and Longevity Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Anti-aging and Longevity Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Anti-aging and Longevity Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Anti-aging and Longevity Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Anti-aging and Longevity Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Anti-aging and Longevity Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Anti-aging and Longevity Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Anti-aging and Longevity Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Anti-aging and Longevity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Anti-aging and Longevity Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Anti-aging and Longevity Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Anti-aging and Longevity Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Anti-aging and Longevity Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Anti-aging and Longevity Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Anti-aging and Longevity Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Anti-aging and Longevity Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Anti-aging and Longevity Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Anti-aging and Longevity Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Anti-aging and Longevity Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Anti-aging and Longevity Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Anti-aging and Longevity Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Anti-aging and Longevity Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Anti-aging and Longevity Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Anti-aging and Longevity Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Anti-aging and Longevity Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Anti-aging and Longevity Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Anti-aging and Longevity Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. The Vitamin Shoppe Company Information
 Table 71. The Vitamin Shoppe Description and Business Overview
 Table 72. The Vitamin Shoppe Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. The Vitamin Shoppe Anti-aging and Longevity Drugs Product
 Table 74. The Vitamin Shoppe Recent Developments/Updates
 Table 75. Natrol Company Information
 Table 76. Natrol Description and Business Overview
 Table 77. Natrol Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Natrol Anti-aging and Longevity Drugs Product
 Table 79. Natrol Recent Developments/Updates
 Table 80. HUM Nutrition Company Information
 Table 81. HUM Nutrition Description and Business Overview
 Table 82. HUM Nutrition Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. HUM Nutrition Anti-aging and Longevity Drugs Product
 Table 84. HUM Nutrition Recent Developments/Updates
 Table 85. Nature Made Company Information
 Table 86. Nature Made Description and Business Overview
 Table 87. Nature Made Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Nature Made Anti-aging and Longevity Drugs Product
 Table 89. Nature Made Recent Developments/Updates
 Table 90. New Chapter Company Information
 Table 91. New Chapter Description and Business Overview
 Table 92. New Chapter Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. New Chapter Anti-aging and Longevity Drugs Product
 Table 94. New Chapter Recent Developments/Updates
 Table 95. Centrum Company Information
 Table 96. Centrum Description and Business Overview
 Table 97. Centrum Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Centrum Anti-aging and Longevity Drugs Product
 Table 99. Centrum Recent Developments/Updates
 Table 100. Pure Encapsulations Company Information
 Table 101. Pure Encapsulations Description and Business Overview
 Table 102. Pure Encapsulations Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Pure Encapsulations Anti-aging and Longevity Drugs Product
 Table 104. Pure Encapsulations Recent Developments/Updates
 Table 105. Nature's Bounty Company Information
 Table 106. Nature's Bounty Description and Business Overview
 Table 107. Nature's Bounty Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Nature's Bounty Anti-aging and Longevity Drugs Product
 Table 109. Nature's Bounty Recent Developments/Updates
 Table 110. MegaFood Company Information
 Table 111. MegaFood Description and Business Overview
 Table 112. MegaFood Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. MegaFood Anti-aging and Longevity Drugs Product
 Table 114. MegaFood Recent Developments/Updates
 Table 115. GNC Company Information
 Table 116. GNC Description and Business Overview
 Table 117. GNC Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. GNC Anti-aging and Longevity Drugs Product
 Table 119. GNC Recent Developments/Updates
 Table 120. Herbalmax Company Information
 Table 121. Herbalmax Description and Business Overview
 Table 122. Herbalmax Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Herbalmax Anti-aging and Longevity Drugs Product
 Table 124. Herbalmax Recent Developments/Updates
 Table 125. GeneHarbor (Hong Kong) Biotechnologies Limited Company Information
 Table 126. GeneHarbor (Hong Kong) Biotechnologies Limited Description and Business Overview
 Table 127. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. GeneHarbor (Hong Kong) Biotechnologies Limited Anti-aging and Longevity Drugs Product
 Table 129. GeneHarbor (Hong Kong) Biotechnologies Limited Recent Developments/Updates
 Table 130. Xiamen Kingdomway Group Company Company Information
 Table 131. Xiamen Kingdomway Group Company Description and Business Overview
 Table 132. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Xiamen Kingdomway Group Company Anti-aging and Longevity Drugs Product
 Table 134. Xiamen Kingdomway Group Company Recent Developments/Updates
 Table 135. Shinkowa Company Information
 Table 136. Shinkowa Description and Business Overview
 Table 137. Shinkowa Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Shinkowa Anti-aging and Longevity Drugs Product
 Table 139. Shinkowa Recent Developments/Updates
 Table 140. Yaben Chemical Company Information
 Table 141. Yaben Chemical Description and Business Overview
 Table 142. Yaben Chemical Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Yaben Chemical Anti-aging and Longevity Drugs Product
 Table 144. Yaben Chemical Recent Developments/Updates
 Table 145. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Company Information
 Table 146. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 147. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product
 Table 149. Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 150. China Resources Double-Crane Pharmaceutical Co.,Ltd. Company Information
 Table 151. China Resources Double-Crane Pharmaceutical Co.,Ltd. Description and Business Overview
 Table 152. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. China Resources Double-Crane Pharmaceutical Co.,Ltd. Anti-aging and Longevity Drugs Product
 Table 154. China Resources Double-Crane Pharmaceutical Co.,Ltd. Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Anti-aging and Longevity Drugs Distributors List
 Table 158. Anti-aging and Longevity Drugs Customers List
 Table 159. Anti-aging and Longevity Drugs Market Trends
 Table 160. Anti-aging and Longevity Drugs Market Drivers
 Table 161. Anti-aging and Longevity Drugs Market Challenges
 Table 162. Anti-aging and Longevity Drugs Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-aging and Longevity Drugs
 Figure 2. Global Anti-aging and Longevity Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Anti-aging and Longevity Drugs Market Share by Type: 2023 & 2030
 Figure 4. Nicotinamide Mononucleotide (NMN) Product Picture
 Figure 5. Vitamins Product Picture
 Figure 6. Resveratrol Product Picture
 Figure 7. Coenzyme Q10 and Collagen Product Picture
 Figure 8. Biotin Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Anti-aging and Longevity Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 11. Global Anti-aging and Longevity Drugs Market Share by Application: 2023 & 2030
 Figure 12. Hospitals
 Figure 13. Retail Pharmacies
 Figure 14. Clinics
 Figure 15. Online Pharmacies
 Figure 16. Global Anti-aging and Longevity Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Anti-aging and Longevity Drugs Market Size (2019-2030) & (US$ Million)
 Figure 18. Global Anti-aging and Longevity Drugs Sales (2019-2030) & (K Units)
 Figure 19. Global Anti-aging and Longevity Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 20. Anti-aging and Longevity Drugs Report Years Considered
 Figure 21. Anti-aging and Longevity Drugs Sales Share by Manufacturers in 2023
 Figure 22. Global Anti-aging and Longevity Drugs Revenue Share by Manufacturers in 2023
 Figure 23. Global 5 and 10 Largest Anti-aging and Longevity Drugs Players: Market Share by Revenue in Anti-aging and Longevity Drugs in 2023
 Figure 24. Anti-aging and Longevity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 25. Global Anti-aging and Longevity Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 26. North America Anti-aging and Longevity Drugs Sales Market Share by Country (2019-2030)
 Figure 27. North America Anti-aging and Longevity Drugs Revenue Market Share by Country (2019-2030)
 Figure 28. United States Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Canada Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Europe Anti-aging and Longevity Drugs Sales Market Share by Country (2019-2030)
 Figure 31. Europe Anti-aging and Longevity Drugs Revenue Market Share by Country (2019-2030)
 Figure 32. Germany Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. France Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. U.K. Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Italy Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Russia Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Asia Pacific Anti-aging and Longevity Drugs Sales Market Share by Region (2019-2030)
 Figure 38. Asia Pacific Anti-aging and Longevity Drugs Revenue Market Share by Region (2019-2030)
 Figure 39. China Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Japan Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. South Korea Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. India Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Australia Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. China Taiwan Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Southeast Asia Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Latin America Anti-aging and Longevity Drugs Sales Market Share by Country (2019-2030)
 Figure 47. Mexico Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Brazil Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Argentina Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Colombia Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Middle East and Africa Anti-aging and Longevity Drugs Sales Market Share by Country (2019-2030)
 Figure 52. Middle East and Africa Anti-aging and Longevity Drugs Revenue Market Share by Country (2019-2030)
 Figure 53. Turkey Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Saudi Arabia Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. UAE Anti-aging and Longevity Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 56. Global Sales Market Share of Anti-aging and Longevity Drugs by Type (2019-2030)
 Figure 57. Global Revenue Market Share of Anti-aging and Longevity Drugs by Type (2019-2030)
 Figure 58. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 59. Global Sales Market Share of Anti-aging and Longevity Drugs by Application (2019-2030)
 Figure 60. Global Revenue Market Share of Anti-aging and Longevity Drugs by Application (2019-2030)
 Figure 61. Global Anti-aging and Longevity Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 62. Anti-aging and Longevity Drugs Value Chain
 Figure 63. Anti-aging and Longevity Drugs Production Process
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure